Correlation Between Citigroup and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Citigroup and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and SAB Biotherapeutics, you can compare the effects of market volatilities on Citigroup and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and SAB Biotherapeutics.
Diversification Opportunities for Citigroup and SAB Biotherapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Citigroup and SAB is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Citigroup i.e., Citigroup and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Citigroup and SAB Biotherapeutics
Taking into account the 90-day investment horizon Citigroup is expected to generate 1.44 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Citigroup is 3.98 times less risky than SAB Biotherapeutics. It trades about 0.38 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 170.00 in SAB Biotherapeutics on April 30, 2025 and sell it today you would earn a total of 83.00 from holding SAB Biotherapeutics or generate 48.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Citigroup vs. SAB Biotherapeutics
Performance |
Timeline |
Citigroup |
SAB Biotherapeutics |
Citigroup and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Citigroup and SAB Biotherapeutics
The main advantage of trading using opposite Citigroup and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.Citigroup vs. Bank of America | Citigroup vs. Wells Fargo | Citigroup vs. JPMorgan Chase Co | Citigroup vs. Toronto Dominion Bank |
SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Senti Biosciences | SAB Biotherapeutics vs. Cingulate | SAB Biotherapeutics vs. Dermata Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |